查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1993146

動脈舌封堵器市場：依封堵機制、材料、最終用途、應用及通路分類－2026-2032年全球市場預測

Arteriotomy Closure Devices Market by Closure Mechanism, Material, End Use, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，動脈閉合裝置市場價值將達到 14.3 億美元，到 2026 年將成長至 15.2 億美元，到 2032 年將達到 22.6 億美元，複合年成長率為 6.78%。

主要市場統計數據
基準年 2025 14.3億美元
預計年份：2026年 15.2億美元
預測年份 2032 22.6億美元
複合年成長率 (%) 6.78%

對動脈扭轉閉合裝置市場進行簡要概述，提供影響策略決策的臨床、供應鏈和商業性因素概述。

動脈閉合器械市場處於介入性心臟病學、周邊血管介入和介入放射學的交匯點，手術效率和病人安全是醫院和門診採購及臨床路徑制定的基礎。器械設計、材料科學和手術流程的創新改變了臨床醫生的選擇偏好。同時，支付方的嚴格審查和基於價值的醫療模式提高了對治療效果和後續醫療成本改善的顯著要求。本執行摘要整合了近期臨床、監管和商業性方面的最新進展，旨在為決策者制定資本計劃、產品開發和打入市場策略提供切實可行的見解。

技術、流程和供應鏈的重大變革正在重塑醫療設備選擇的臨床引入、採購重點和競爭差異化。

過去幾年，動脈閉合領域經歷了變革性的轉變，這主要得益於技術、手術流程和治療模式的同步發展。器械技術已從傳統的縫合系統發展到日益多樣化的組合式系統，這些系統強調快速止血、縮短下床活動時間以及與經皮大直徑入路的兼容性。與器械創新相輔相成的是，臨床醫生正在採用手術流程標準化和影像引導技術來減少治療結果的差異，這正在影響醫院的器械採納曲線和採購優先順序。

關稅引起的成本壓力和供應鏈中斷對採購決策、定價趨勢和策略採購重點的影響（截至 2025 年）。

2025年，美國實施或調整的關稅措施的累積影響將波及動脈切開和閉合器械的整個價值鏈，對零件採購、生產計畫和定價策略產生顯著影響。關稅壓力加劇了依賴進口原料和零件的製造商的成本敏感性，進而影響其庫存緩衝和供應商多元化決策。為此，一些製造商正在加快本地化進程，並與供應商重新談判契約，以降低關稅波動和海關延誤帶來的風險。

從綜合細分的觀點，將機制、臨床環境、材料成分和分銷管道與推動採用和商業化的因素聯繫起來。

詳細的市場區隔分析揭示了器材設計、臨床環境和材料選擇如何相互交織，共同塑造產品上市模式和市場進入策略。根據閉合機制，市場可細分為夾式系統、塞式解決方案、密封劑產品和縫合式器械。夾式系統可細分為金屬夾和聚合物夾，塞式解決方案可細分為膠原蛋白塞和各種聚合物塞，縫合式產品則可細分為可吸收和不可吸收兩種類型。這些機制上的差異會影響臨床醫生的選擇，因為他們需要在易用性、器械形狀和對特定入路尺寸的適用性之間取得平衡，同時也決定了產品的製造複雜性和監管核准流程。

支付方行為、監管複雜性以及程序採用的細微區域差異，決定了差異化的商業化和證據產生策略。

區域趨勢持續對產品開發重點、監管策略和商業計劃產生重大影響。在美洲，醫療系統優先考慮能夠提高效率並支援當天出院的技術，而支付方則越來越關注治療結果和打包支付模式。這促使那些能夠縮短住院時間並顯著降低併發症發生率的醫療器材被推廣。在歐洲、中東和非洲，法規結構的多樣性和不同的報銷環境通常需要針對多個地區制定證據包和適應性定價策略才能進入市場。同時，歐洲主要市場的領先醫療中心推動了臨床應用，這種趨勢隨後會輻射到鄰近的醫療系統。

競爭格局正在向強調證據生成、有針對性的夥伴關係和綜合服務模式的方向轉變，以促進差異化和推廣應用。

動脈閉合領域的競爭格局呈現出多元化的特點，既有成熟的醫療設備製造商，也有專注於特定領域的專業製造商，以及利用新型材料和簡化導入技術的新興參與企業。主要企業正優先進行臨床證據的收集、完善的上市後監測以及臨床醫生培訓項目，以降低治療結果的差異性，並加速在高頻醫療機構中的應用。該市場普遍採取的策略性措施包括：透過有針對性的收購來拓展產品系列；與契約製造製造商合作以快速提升產能；以及投資收集和分析真實世界臨床數據，以便與監管機構和保險公司進行溝通。

企業應採取具有重大影響力的營運、臨床證據和商業舉措，以加強其市場地位並加速推廣應用。

產業領導企業應透過一系列協調一致的舉措，整合產品、臨床和商業策略，從而建立強大的競爭優勢。首先，他們應優先開發和傳播可靠的真實世界證據和以臨床醫生主導的療效研究，將設備性能與可衡量的改進（例如提高患者容量和減少併發症）聯繫起來。其次，他們應重新設計供應鏈，透過認證替代供應商，並在可能的情況下探索區域製造方案，以降低關稅波動和單一來源風險的影響。第三，他們應針對特定臨床環境，建立量身定做的市場進入模式，為門診手術中心、導管檢查室和醫院系統提供有針對性的培訓和支持，確保每個管道都能獲得適當的部署支援和部署後跟進。

採用嚴謹的混合方法研究途徑，結合臨床醫師訪談、文獻回顧和使用真實世界資料的檢驗，以檢驗策略見解。

本分析整合了初級和次級研究方法，以確保研究結果在臨床、商業性和監管層面檢驗。初級資料包括對介入性心臟病專家、血管外科醫師、介入性放射科醫師、採購經理和產品經理的結構化訪談，並輔以專注於醫療設備選擇標準和手術流程的臨床醫生問卷。次級研究納入了同行評審的臨床文獻、監管文件和專業學會發布的指南，以提供關於醫療設備性能和安全性的論點的背景資訊。數據三角測量技術用於校正資訊來源之間的差異並突出一致的主題。

強調證據一致性、供應鏈韌性和有針對性的商業化的策略整合是實現永續競爭優勢的關鍵要素。

總而言之，動脈閉合器材的市場格局正日趨成熟，各種解決方案在提供可證實的臨床獲益的同時，也不斷適應不斷變化的醫療服務和報銷模式。技術創新、手術向門診轉移以及關稅趨勢帶來的供應鏈壓力，共同影響產品的選擇和商業化策略。那些能夠將實證實踐與營運價值提案結合，並著力提升供應鏈韌性的相關人員，將更有能力影響採購決策和臨床路徑。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依閉合機制分類的動脈舌閉合裝置市場

  • 夾子類型
    • 金屬夾
    • 聚合物夾
  • 插頭類型
    • 膠原蛋白塞
    • 聚合物塞
  • 密封劑類型
  • 縫合基部
    • 吸收性
    • 不吸收

第9章：動脈舌封堵器市場：依材料分類

  • 膠原蛋白
  • 金屬
  • 聚合物

第10章：動脈舌封堵器市場：依最終用途分類

  • 門診手術中心
  • 心臟導管檢查室
  • 醫院
    • 私立醫院
    • 公立醫院

第11章：動脈舌閉合裝置市場：依應用領域分類

  • 循環系統
  • 周邊血管
  • 放射科

第12章：動脈舌封堵器市場：依通路分類

  • 直銷
  • 銷售代理
  • 線上供應商

第13章：動脈舌封堵器市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：動脈舌閉合裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：動脈舌封堵器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國動脈造口閉合裝置市場

第17章：中國動脈切割和閉合器械市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Aesculap, Inc.
  • Arstasis, Inc.
  • Artivion, Inc.
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CytoSorbents Corporation
  • Fumedica AG
  • Humacyte Global Inc.
  • iVascular, SLU
  • IVT Medical Ltd.
  • KOAG LLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems, Inc.
  • Mitralign Inc.
  • Teleflex Incorporated
  • Terumo Medical Corporation
  • TOTAL Vein Solutions, LLC
  • Transluminal Technologies Inc.
  • Tricol Biomedical Inc.
  • Vasorum Ltd.
Product Code: MRR-1A1A064C02DB

The Arteriotomy Closure Devices Market was valued at USD 1.43 billion in 2025 and is projected to grow to USD 1.52 billion in 2026, with a CAGR of 6.78%, reaching USD 2.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.43 billion
Estimated Year [2026] USD 1.52 billion
Forecast Year [2032] USD 2.26 billion
CAGR (%) 6.78%

A concise orientation to the arteriotomy closure device environment that frames clinical, supply chain, and commercial forces shaping strategic decision-making

The arteriotomy closure device space sits at the intersection of interventional cardiology, peripheral vascular intervention, and interventional radiology, with procedural efficiency and patient safety shaping procurement and clinical pathways across hospitals and ambulatory settings. Innovations in device design, material science, and procedural workflows have altered operator preferences, while payer scrutiny and value-based care models are raising the bar for demonstrable improvements in outcomes and downstream cost of care. This executive summary synthesizes recent clinical, regulatory, and commercial dynamics to equip decision-makers with pragmatic intelligence for capital planning, product development, and market access strategies.

In addition, stakeholders must navigate a complex supplier network spanning component manufacturers, device OEMs, and distribution partners. The shift of many procedures to outpatient and ambulatory surgical centers has introduced different purchasing frameworks and clinical requirements, influencing the types of closure mechanisms preferred by clinicians. Given this backdrop, the following sections unpack transformative shifts in clinical practice, tariff impacts that have reshaped supply chain calculus in the United States, segmentation-driven insights, regional nuances, competitor behavior, and concrete recommendations for leaders aiming to maintain or extend competitive advantage.

Critical technological, procedural, and supply chain shifts that are reshaping clinical adoption, procurement priorities, and competitive differentiation in device selection

Over the past several years, the landscape for arteriotomy closure has undergone a series of transformative shifts driven by concurrent technological, procedural, and delivery-model changes. Device technologies have evolved from traditional suture-based systems toward an increasingly diverse mix that emphasizes rapid hemostasis, reduced time to ambulation, and compatibility with percutaneous large-bore access. Complementing device innovation, clinicians have embraced procedural standardization and imaging-guided approaches that reduce variability in outcomes, which in turn affects hospital adoption curves and purchasing priorities.

Operationally, the migration of select interventions to ambulatory surgical centers and same-day discharge pathways has influenced product selection toward devices that simplify workflows and minimize the need for extended post-procedure monitoring. Regulatory emphasis on real-world evidence and post-market surveillance has raised expectations for rigorous clinical data, prompting manufacturers to invest in registries and longitudinal outcome tracking. Concurrently, supply chain resiliency has become a strategic priority after recent disruptions, motivating some organizations to diversify suppliers and source critical materials closer to manufacturing hubs. Taken together, these shifts have increased the premium on devices that combine clinical performance with clear value narratives tied to efficiency, safety, and total cost of care.

How tariff-driven cost pressures and supply chain disruptions have influenced sourcing decisions, pricing dynamics, and strategic procurement priorities through 2025

The cumulative impact of United States tariff measures enacted and adjusted through 2025 has reverberated across the arteriotomy closure device value chain, with measurable effects on component sourcing, production planning, and pricing strategies. Tariff pressures have increased the cost sensitivity for manufacturers that rely on imported raw materials and components, subsequently influencing decisions regarding inventory buffering and supplier diversification. In response, some manufacturers have accelerated localization initiatives and renegotiated supplier contracts to mitigate exposure to tariff volatility and customs delays.

Procurement teams at hospitals and ambulatory centers have faced tighter negotiations as suppliers pass through incremental costs or seek long-term purchase agreements to stabilize volumes. At the same time, the tariff environment has prompted a reexamination of supply chain risk assessments, with greater emphasis on dual sourcing, contractual flexibility, and longer lead-time planning. For product managers, the tariff landscape has created an imperative to articulate cost-to-serve and total lifecycle benefits more clearly, so that incremental procurement premiums can be justified by demonstrable reductions in post-procedural complications, shortened length of stay, or decreased device reinterventions. Ultimately, tariff-driven cost pressures have reinforced the strategic importance of supply chain transparency and proactive engagement with procurement stakeholders to maintain market access and preserve pricing power.

An integrated segmentation perspective linking mechanism, clinical setting, material composition, and distribution channels to adoption drivers and commercialization choices

Deep segmentation analysis reveals how device design, clinical setting, and material selection collectively shape adoption patterns and go-to-market strategies. Based on closure mechanism, the market encompasses clip based systems, plug based solutions, sealant based products, and suture based devices; clip based systems are differentiated further by metallic clips and polymer clips, while plug based solutions segment into collagen plug and polymer plug variants, and suture based options split into absorbable and nonabsorbable formats. These mechanistic differences influence operator choice by balancing ease of use, device profile, and compatibility with specific access sizes, and they also dictate manufacturing complexity and regulatory pathways.

Based on end use, the clinical environment spans ambulatory surgical centers, cardiac catheterization laboratories, and hospitals, with hospitals subdivided into private hospitals and public hospitals; each setting imposes distinct procurement cycles, staff competencies, and reimbursement realities. Devices intended for ambulatory surgical centers often prioritize rapid hemostasis and minimal monitoring requirements, whereas those deployed in catheterization labs must integrate with high-throughput procedural lists and operator preferences. Based on application, clinical utilization covers cardiology procedures, peripheral vascular interventions, and radiology-guided access, and these applications vary in access size, anticoagulation practices, and post-procedure care pathways, all of which dictate product specifications and training needs.

Based on material, device platforms are developed using collagen, metallic, and polymeric materials, each presenting distinct trade-offs in bioresorption, inflammatory profile, and manufacturing cost. Material choice carries implications for regulatory submissions, post-market surveillance, and differentiation in clinical evidence. Finally, based on distribution channel, devices reach end-users through direct sales forces, distributors, and online vendors; channel strategy impacts the sales model, training delivery, and after-sales service expectations. Direct sales often enable clinical training and integrated value messaging, while distributors and online vendors can expand reach but may require complementary support programs to ensure proper adoption and device utilization.

Regional nuances in payer behavior, regulatory complexity, and procedural growth that determine differentiated commercialization and evidence generation tactics

Regional dynamics continue to exert a meaningful influence on product development priorities, regulatory strategy, and commercial planning. In the Americas, health systems emphasize efficiency gains and technologies that support same-day discharge, with payers increasingly focused on outcomes and bundled payment models; this encourages devices that reduce length of stay and demonstrably lower complication rates. Across Europe, Middle East & Africa, heterogeneous regulatory frameworks and varied reimbursement environments mean market entry often requires multiple localized evidence packages and adaptive pricing strategies, while centers of excellence in major European markets drive clinical adoption that subsequently diffuses to neighboring health systems.

In Asia-Pacific, rapid procedural growth, hospital expansion, and cost-conscious procurement shape demand for scalable device platforms and streamlined training programs. Local manufacturing capabilities and regional supply chain hubs in several Asia-Pacific markets also alter sourcing calculus for global manufacturers seeking cost-effective production. Transitional shifts across these regions-such as the expansion of ambulatory care models in the Americas, regulatory convergence in parts of Europe, Middle East & Africa, and investment in interventional facilities in Asia-Pacific-underscore the need for market-specific evidence, adaptive commercialization playbooks, and flexible partnership structures to capture regional opportunities effectively.

Competitive landscape dynamics emphasizing evidence generation, targeted partnerships, and integrated service models that drive differentiation and adoption

Competitive dynamics in the arteriotomy closure arena are defined by a mix of entrenched medical device players, specialized niche manufacturers, and emerging entrants that leverage novel materials or simplified deployment techniques. Leading companies prioritize clinical evidence generation, robust post-market surveillance, and clinician training programs to reduce variability in outcomes and accelerate adoption among high-volume operators. Strategic behaviors observed across the landscape include targeted acquisitions to broaden product portfolios, partnerships with contract manufacturers to scale production capacity quickly, and investments in gather-and-analyze initiatives that aggregate real-world outcomes for regulatory and payer engagement.

Market leaders also differentiate through comprehensive services such as on-site training, proctoring, and integrated data platforms that track device performance across institutions. Meanwhile, mid-sized and smaller firms often compete on innovation speed, introducing iterative improvements in device profile, deployment simplicity, or material composition that appeal to specific clinical niches. Across the competitive set, success correlates strongly with the ability to articulate a clear value proposition that connects clinical advantages to operational efficiencies and economic outcomes valued by purchasing committees, while maintaining supply chain continuity and regulatory compliance.

High-impact operational, clinical evidence, and commercial actions that companies should implement to strengthen market position and accelerate adoption

Industry leaders should pursue a set of coordinated actions that align product, clinical, and commercial strategies to create defensible advantages. First, prioritize development and communication of robust real-world evidence and clinician-authored outcomes studies that link device performance with measurable improvements in patient throughput and complication reduction. Second, redesign supply chain architectures to reduce exposure to tariff volatility and single-source risks by qualifying alternate suppliers and exploring regional manufacturing options where feasible. Third, tailor go-to-market models to specific clinical settings by providing targeted training and support for ambulatory surgical centers, catheterization labs, and hospital systems, ensuring that each channel receives appropriate onboarding and post-implementation follow-up.

Additionally, invest in material and design optimization that reduces procedural complexity, shortens deployment time, and favors compatibility across common access sizes. Engage early with payers and hospital procurement teams to build value dossiers that translate clinical benefits into procurement-relevant economic terms. Finally, consider strategic partnership models with distributors and technology platforms to extend reach while maintaining clinical oversight, and commit to continuous post-market surveillance to support regulatory compliance and iterative product improvement. These combined actions will help organizations manage near-term headwinds while positioning them for sustainable growth as procedural pathways and care delivery models evolve.

A rigorous mixed-methods research approach combining clinician interviews, literature review, and real-world evidence triangulation to validate strategic findings

This analysis synthesizes primary and secondary research methods to ensure findings are validated across clinical, commercial, and regulatory dimensions. Primary inputs included structured interviews with interventional cardiologists, vascular surgeons, interventional radiologists, procurement leaders, and product managers, supplemented by clinician surveys focused on device selection criteria and procedural workflows. Secondary research incorporated peer-reviewed clinical literature, regulatory filings, and published professional society guidance to contextualize device performance and safety assertions. Data triangulation techniques were applied to reconcile differences across sources and highlight consistent themes.

Where possible, real-world registry data and post-market surveillance summaries were reviewed to assess longer-term outcomes and complication profiles. The methodology emphasized source transparency, cataloging interview samples and inclusion criteria to support reproducibility. Finally, limitations are acknowledged: the analysis focuses on observable trends and stakeholder perspectives rather than proprietary contractual terms, and readers should interpret anecdotal insights alongside documented clinical evidence. Despite these constraints, the research approach provides a robust foundation for strategic decision-making by combining practitioner insights with documented clinical and regulatory information.

A strategic synthesis emphasizing evidence alignment, supply chain resilience, and targeted commercialization as imperatives for sustained competitive advantage

In summary, the arteriotomy closure device environment is maturing toward solutions that deliver demonstrable clinical benefits while fitting within evolving care delivery and reimbursement models. Technological innovation, procedural shifts toward outpatient care, and supply chain pressures driven by tariff dynamics have collectively influenced product selection and commercialization strategies. Stakeholders that align evidence generation with operational value propositions and address supply chain resiliency will be best positioned to influence purchasing decisions and clinical pathways.

Decision-makers should treat this juncture as an opportunity to refine product roadmaps, strengthen relationships with clinical champions, and proactively engage payers with robust outcome data. By doing so, organizations can convert the current period of transformation into a sustained advantage, enabling safer, more efficient patient care and clearer economic value for health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Arteriotomy Closure Devices Market, by Closure Mechanism

  • 8.1. Clip Based
    • 8.1.1. Metallic Clip
    • 8.1.2. Polymer Clip
  • 8.2. Plug Based
    • 8.2.1. Collagen Plug
    • 8.2.2. Polymer Plug
  • 8.3. Sealant Based
  • 8.4. Suture Based
    • 8.4.1. Absorbable
    • 8.4.2. Non Absorbable

9. Arteriotomy Closure Devices Market, by Material

  • 9.1. Collagen
  • 9.2. Metallic
  • 9.3. Polymeric

10. Arteriotomy Closure Devices Market, by End Use

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Catheterization Laboratories
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals

11. Arteriotomy Closure Devices Market, by Application

  • 11.1. Cardiology
  • 11.2. Peripheral Vascular
  • 11.3. Radiology

12. Arteriotomy Closure Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Vendors

13. Arteriotomy Closure Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Arteriotomy Closure Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Arteriotomy Closure Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Arteriotomy Closure Devices Market

17. China Arteriotomy Closure Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Aesculap, Inc.
  • 18.7. Arstasis, Inc.
  • 18.8. Artivion, Inc.
  • 18.9. Boston Scientific Corporation
  • 18.10. Cardinal Health, Inc.
  • 18.11. CytoSorbents Corporation
  • 18.12. Fumedica AG
  • 18.13. Humacyte Global Inc.
  • 18.14. iVascular, S.L.U
  • 18.15. IVT Medical Ltd.
  • 18.16. KOAG LLC
  • 18.17. Medtronic plc
  • 18.18. Meril Life Sciences Pvt. Ltd.
  • 18.19. Merit Medical Systems, Inc.
  • 18.20. Mitralign Inc.
  • 18.21. Teleflex Incorporated
  • 18.22. Terumo Medical Corporation
  • 18.23. TOTAL Vein Solutions, LLC
  • 18.24. Transluminal Technologies Inc.
  • 18.25. Tricol Biomedical Inc.
  • 18.26. Vasorum Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC CLIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC CLIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC CLIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN PLUG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN PLUG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN PLUG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER PLUG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER PLUG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER PLUG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SEALANT BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SEALANT BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SEALANT BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMERIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMERIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMERIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ONLINE VENDORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ONLINE VENDORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ONLINE VENDORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 177. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 178. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 179. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 180. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 207. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 208. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 209. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 210. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 212. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 213. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 217. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 218. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 219. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 220. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 221. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 222. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 223. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)